MAM
ALBO

Meeder Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Meeder Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,731
Closed -$92K – 2338
2020
Q3 		$92K Buy
+2,731
New +$79.6K 0.01% 807
2020
Q2 		– Sell
-689
Closed -$11K – 2602
2020
Q1 		$11K Buy
689
+231
+50% +$5.08K ﹤0.01% 1496
2019
Q4 		$11K Buy
458
+12
+3% +$240 ﹤0.01% 1544
2019
Q3 		$9K Sell
446
-1,580
-78% -$40.9K ﹤0.01% 1584
2019
Q2 		$65K Buy
2,026
+1,800
+796% +$60.2K ﹤0.01% 878
2019
Q1 		$7K Buy
226
+35
+18% +$942 ﹤0.01% 1337
2018
Q4 		$5K Buy
+191
New +$5.05K ﹤0.01% 1432

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Meeder Asset Management's ALBO Position: Q4 2020 in Review

Meeder Asset Management sold out of Albireo Pharma Inc (ALBO) in Q4 2020, closing a stake of 2,731 shares — an estimated $92K sold.

Meeder Asset Management first reported a position in ALBO in Q4 2018 and held it in 7 quarters. The position peaked at $92K in Q3 2020. 107 funds tracked by Wall St. Rank hold ALBO as of Q4 2020.

  • Meeder Asset Management reported no remaining Albireo Pharma Inc position as of Q4 2020 after selling out during the quarter.
  • Meeder Asset Management sold 2,731 Albireo Pharma Inc shares in Q4 2020, an estimated $92K.
  • Meeder Asset Management first reported a position in Albireo Pharma Inc in Q4 2018 and held it in 7 quarters.
  • Meeder Asset Management's Albireo Pharma Inc position peaked at $92K in Q3 2020.
  • 107 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.